Screening Toxic Chemicals: How Accurate Must Tests Be?

A decision analysis framework is used to explore the value of screening tests for carcinogenicity. Whether a test lowers the social cost of screening depends on the test's sensitivity, specificity, and cost and the social cost of misclassification (exonerating carcinogenic chemicals or condemning noncarcinogenic chemicals). The model shows that the best screening test need not be either the most accurate or the least expensive.

[1]  D. Hattis The promise of molecular epidemiology for quantitative risk assessment. , 1986, Risk analysis : an official publication of the Society for Risk Analysis.

[2]  Talbot Page,et al.  Priority Setting for Testing Chemicals , 1983 .

[3]  F. Perera New approaches in risk assessment for carcinogens. , 1986, Risk analysis : an official publication of the Society for Risk Analysis.

[4]  J H Weisburger,et al.  Carcinogen testing: current problems and new approaches. , 1981, Science.

[5]  H S Rosenkranz,et al.  Application of the carcinogenicity prediction and battery selection (CPBS) method to the Gene-Tox data base. , 1985, Mutation research.

[6]  J. Ashby,et al.  Evaluation of short-term tests for carcinogens : report of the international collaborative program , 1981 .

[7]  H S Rosenkranz,et al.  Cluster analysis in predicting the carcinogenicity of chemicals using short-term assays. , 1985, Mutation research.

[8]  L B Lave,et al.  Health and safety risk analyses: information for better decisions. , 1987, Science.

[9]  I. Weinstein The monitoring of DNA adducts as an approach to carcinogen detection. , 1983, Annual review of public health.

[10]  V. Dunkel,et al.  Reliability of the hepatocyte primary culture/DNA repair test in testing of coded carcinogens and noncarcinogens. , 1982, Mutation research.

[11]  D. W. Roncek,et al.  Discrete Discriminant Analysis. , 1979 .

[12]  Kathleen D. Heffernan,et al.  A MODEL FOR SELECTING SHORT‐TERM TESTS OF CARCINOGENICITY , 1983 .

[13]  Talbot Page,et al.  A Generic View of Toxic Chemicals and Similar Risks , 1978 .

[14]  D. Mebs,et al.  Toxicity Testing. Strategies to Determine Needs and Priorities: U.S. National Toxicology Program. 382 pp. Washington, DC: National Academy Press (1984) , 1987 .

[15]  Richard A. Merrill,et al.  Risk Quantitation and Regulatory Policy , 1985 .

[16]  B. Ames,et al.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. , 1975, Mutation research.

[17]  I. Purchase,et al.  An appraisal of predictive tests for carcinogenicity , 1982 .

[18]  L. Lave Improving the management of environmental health. , 1985, Environmental health perspectives.

[19]  R. Montesano Screening tests in chemical carcinogenesis : proceedings of a workshop organized by IARC and the Commission of the European Communities and held in Brussels, Belgium, 9-12 June 1975 , 1976 .

[20]  Lester B. Lave,et al.  Cost-effectiveness of short-term tests for carcinogenicity , 1986, Nature.

[21]  H S Rosenkranz,et al.  The carcinogenicity prediction and battery selection (CPBS) method: a Bayesian approach. , 1985, Mutation research.

[22]  E. Hook International Commission for Protection against Environmental Mutagens and Carcinogens. , 1983, Mutation research.

[23]  J. Ashby,et al.  Evaluation of short-term tests for carcinogens , 1988 .